Mark Burkard, MD, PhD, discussed genomic gaps, extreme survivors of metastatic breast cancer, and how minimal residual disease testing may refine care.
|Articles|July 15, 2019
Dr. Fergus Couch on New Genes Implicated in Triple-Negative Breast Cancer Risk
Author(s)Fergus Couch, PhD
Cancer Network spoke with Fergus Couch, PhD, professor and researcher at the Mayo Clinic in Rochester, Minnesota, about new genes implicated in triple-negative breast cancer risk.
Advertisement
Cancer Network spoke with Fergus Couch, PhD, professor and researcher at the Mayo Clinic, about new genes implicated in triple-negative breast cancer risk.
Advertisement
Related to this article
Hope S. Rugo, MD, discussed KEYNOTE-B49 data showing pembrolizumab plus chemotherapy improved PFS in PD-L1-positive HR+/HER2- breast cancer.
Jan Kitajewski, PhD, discusses how an ancestry-linked blood type may influence triple-negative breast cancer outcomes and clinical trial eligibility.
Black women die from breast cancer at rates 40% higher than white women — and are still missing from the trials that could help. Dr. Coral Omene on why.
The European Commission approved adjuvant T-DXd for HER2-positive early breast cancer with residual invasive disease based on DESTINY-Breast05 data.
Jan Kitajewski, PhD, explains how Notch inhibitors may sustain specialized tumor blood vessels that deliver immune cells and boost immuno-oncology.
In a phase 3 trial, the Breast Cancer Locator was noninferior to wire localization and lowered positive margin rates in nonpalpable breast cancer.
ASCENT-03 subgroup data show sacituzumab govitecan improved PFS vs chemotherapy across subgroups in untreated metastatic TNBC.
Advertisement
Advertisement
Trending on CancerNetwork
1
Blood mRNA Model Predicts Castration Resistance in Metastatic Prostate Cancer
2
Triplet Therapy Emerges as a First-Line Option in BRAF V600–Mutant Melanoma
3
Prioritizing Biomarker Testing to Conserve Tissue in Gastroesophageal Cancer
4
Choosing Between Triplet Therapy and Immunotherapy in BRAF-Mutant Melanoma
5